IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 199 filers reported holding IMPAX LABORATORIES INC in Q3 2016. The put-call ratio across all filers is 1,411.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $20,431,000 | -27.2% | 1,006,453 | -42.2% | 0.09% | -42.0% |
| Q2 2017 | $28,056,000 | +102.4% | 1,742,578 | +59.1% | 0.16% | +103.9% |
| Q1 2017 | $13,859,000 | +79.9% | 1,095,600 | +88.4% | 0.08% | +42.6% |
| Q4 2016 | $7,704,000 | -42.6% | 581,400 | +2.6% | 0.05% | -42.6% |
| Q3 2016 | $13,426,000 | +538.7% | 566,500 | +848.9% | 0.09% | +452.9% |
| Q3 2015 | $2,102,000 | -75.0% | 59,700 | -67.4% | 0.02% | -70.7% |
| Q2 2015 | $8,403,000 | – | 183,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |